The online home for the primary care professionals managing patients with cardiovascular disease, diabetes and related diseases.

Topic: Anticoagulation - Primary Care

Wednesday, 21 February 2018
Atrial fibrillation (AF) is the commonest sustained cardiac dysrhythmia, but is asymptomatic in about one quarter of patients. Case finding with subsequent assessment of the risk of stroke and bleeding are essential to ensure that the right patients receive appropriate intervention with oral anticoagulation.
Category: Editorial
Tuesday, 11 April 2017
Anticoagulation UK, in collaboration with other charities is hosting the Anticoagulation Achievement Awards 2017 to celebrate outstanding practice in the management, education and provision of anticoagulation across the UK.
Category: Have You Heard
Friday, 02 August 2019
Atrial fibrillation (AF) management has been transformed within the last decade by revised clinical guidance and availability of new drugs. Aspirin monotherapy, once accounting for almost half of all antithrombotic prescriptions for AF, is now an obsolete therapy. Anticoagulation is the treatment of choice for AF and direct oral anticoagulants (DOACs) have overtaken warfarin as the drug of first choice for new starters. However, management of one in four people with AF remains suboptimal, and this article reviews the major issues around antithrombotic and other treatments for AF.
Category: Editorial
Thursday, 28 April 2016
Recent guidelines recommend two key steps to reduce ischaemic stroke in people with atrial fibrillation: 1. Improving the assessment of stroke risk and 2. Increasing the use of evidence-based anticoagulant therapy. In this article, leading specialists explain how to apply current guidelines to improve current practice in stroke prevention.
Category: Editorial
Friday, 30 June 2017
The leading UK cardiovascular conference for the whole primary care team. Expert presenters and a down-to-earth approach help health professionals translate the latest evidence into daily practice and optimise patient care. Participants also receive 9 hours CPD credits. Book now to attend this inspirational event and take advantage of our Early Bird discount.
Category: Editorial
Thursday, 28 January 2021
This article describes a new best practice framework service specification which is available to download free from Anticoagulation UK. The specification has been designed to support services to deliver best practice in anticoagulation diagnosis and management during and beyond the current pandemic.
Category: Editorial
Wednesday, 07 June 2017
A new survey from the Atrial Fibrillation society shows a high level of demand for self-monitoring in people being treated with warfarin. In the survey, 79% of respondents said that they would prefer to self-monitor over clinic visits. New self- monitoring products are being launched.
Category: Have You Heard
Wednesday, 30 May 2018
Patients with atrial fibrillation (AF) still need treatment even after their heart rhythm seems to have returned to normal, according to a recent paper in the BMJ. They remain at a 60% greater risk of stroke or transient ischaemic attack (TIA) than patients without AF.
Friday, 05 November 2021
This updated article from Professor Ahmet Fuat highlights the key considerations that medical professionals should take into account for appropriate dosing of DOACs including the latest specific dose adjustment requirements for each DOAC and the importance of improving patient adherence with DOAC therapy.
Category: Editorial
Friday, 19 May 2017
The direct factor Xa inhibitor rivaroxaban has been showing promise in trials in venous thromboembolism (VTE) and peripheral arterial disease (PAD). We provide details from the EINSTEIN CHOICE and COMPASS trials.
Page 1 of 2

Article search and filter